These studies emphasize that IKKα alone is sufficient to contribute to activation of NF-ĸB pathways, promoting a malignant phenotype and suggest that these mechanisms may be important therapeutic target in treating prostate cancer. The gene discussed is CHUK; the disease is prostate cancer.